• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Long-acting opioid use linked to higher risk of overdose

byShayna BejaimalandJames Jiang
February 19, 2015
in Chronic Disease, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In a cohort of elderly veterans with chronic painful conditions, patients started on long-acting opioids were 2.5 times as likely to have an unintentional overdose as compared to short-acting opioids.

2. The risk of overdose from long-acting opioids was highest in the first 2 weeks after treatment initiation.

Evidence Rating Level: 2 (Good)

Study Rundown: With increased use of opioids for chronic pain management comes a higher risk of opioid overdose. However, few studies have examined the factors other than opioid dose that contribute to overdose risk. The objective of this study was to determine if unintentional opioid overdose was associated with the duration of opioid action. Individuals started on long-acting opioids were 2.5 times as likely to have overdose incidents as compared to patients on short-acting opioids. This risk was five times higher in the first two weeks after treatment initiation.

Strengths of this study include being a large, population-based, propensity score-adjusted cohort study. Limitations of this study include not being able to adjust for data that is not included in the health administrative database. The population was largely elderly male veterans, so the results may not be generalizable to a broader population. Additionally, automated prescription data was used, rather than actual adherence data. Moreover, a significant proportion of patients were excluded, as the population began with over 2 million patients, and ultimately 840,606 patients were included in the analysis.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

The 5x-multiplier algorithm reduces opioids prescribed at discharge

Naldemedine may be effective for opioid-induced constipation in patients with cancer

Relevant Reading: Opioid dose and drug-related mortality in patients with non-malignant pain

In-Depth [retrospective cohort]: This population-based, propensity-score adjusted study used the Veterans Administration Healthcare System (VA) database to examine national pharmacy and healthcare data of 840,606 veterans with chronic painful conditions, from January 2000 to December 2009. The administrative data contained information on opioid dosage, duration of action, and events of hospitalizations for unintentional opioid overdoses. Baseline demographic and clinical information were also collected from the VA. Study participants were propensity-score matched to controls, and multivariate regression models were performed. Hazard ratios were adjusted for age, sex and opioid dose.

A total of 319 unintentional overdose events were observed within the study period. After adjustment for age, sex, and opioid dose, the hazard ratio of overdose events was 2.56 (95%CI 1.67-3.93) for individuals on long-acting opioids as compared to those on short-acting opioids. Adjustment with the remaining covariates reduced the risk slightly, but it remained significant (HR 2.33; 95%CI 1.26-4.32). The overdose risk was greatest in the first two weeks after treatment initiation (HR 5.25, 95%CI 1.88-14.72). The results remained robust through sensitivity analyses.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: opioidsoverdose
Previous Post

Amyloid may cause distant cerebral hypometabolism in Alzheimer’s

Next Post

Diffusion-weighted MRI highly sensitive, specific vs. CT in acute ischemic stroke [Classics Series]

RelatedReports

An illustration representing the process of opioid tapering, with pills arranged on a staircase leading to a seated area, symbolizing behavioral support during withdrawal.
Chronic Disease

The 5x-multiplier algorithm reduces opioids prescribed at discharge

September 13, 2026
Chronic Disease

Naldemedine may be effective for opioid-induced constipation in patients with cancer

September 17, 2024
Chronic Disease

Emergency departments likely overprescribing opioids for acute pain

July 27, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage

May 14, 2024
Next Post
Classics Series, Landmark Trials in Medicine

Diffusion-weighted MRI highly sensitive, specific vs. CT in acute ischemic stroke [Classics Series]

Postmenopausal hormone replacement therapy use associated with increased ovarian cancer risk

Increased risk of subsequent melanoma after first melanoma diagnosis

Increased risk of subsequent melanoma after first melanoma diagnosis

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Inhaled corticosteroids do not improve outcomes in sickle cell disease patients without asthma
  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.